Martin Lechmann
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 14
- Immunology 13
- Biosimilars and Bioanalytical Methods 5
- Toxin Mechanisms and Immunotoxins 2
- Co-authors
- T. Jake Liang (4 shared papers)Tilman Sauerbruch (5 shared papers)Ulrich Spengler (5 shared papers)Kazumoto Murata (3 shared papers)G. Jung (3 shared papers)Rolf Kaiser (2 shared papers)Jujin Satoi (3 shared papers)Rainer P. Woitas (2 shared papers)
- Journals
- Hepatology (4 papers)mAbs (3 papers)Journal of Hepatology (2 papers)Human Gene Therapy (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Martin Lechmann
28 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 69
- Hepatology 599
- Virology 78
- Immunology 308
- Epidemiology 439
- Radiology, Nuclear Medicine and Imaging 264
Countries citing papers authored by Martin Lechmann
This map shows the geographic impact of Martin Lechmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Lechmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Lechmann more than expected).
Fields of papers citing papers by Martin Lechmann
This network shows the impact of papers produced by Martin Lechmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Lechmann. The network helps show where Martin Lechmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Lechmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 138 | |
| 2 | 1996 | 127 | |
| 3 | 2008 | 108 | |
| 4 | 1999 | 104 | |
| 5 | 1997 | 103 | |
| 6 | 2001 | 83 | |
| 7 | 1999 | 71 | |
| 8 | 2000 | 64 | |
| 9 | 2016 | 48 | |
| 10 | Immune responses in hepatitis C virus infection. | 1996 | 39 |
| 11 | 1997 | 36 | |
| 12 | 2006 | 33 | |
| 13 | 2020 | 29 | |
| 14 | 2001 | 27 | |
| 15 | 2017 | 17 | |
| 16 | A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation. | 2000 | 13 |
| 17 | 2021 | 12 | |
| 18 | 2022 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2006 | 6 |
About Martin Lechmann
Martin Lechmann is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Hepatology, Molecular Biology and Epidemiology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Hepatitis C virus research (12 papers), Protein purification and stability (6 papers), Systemic Lupus Erythematosus Research (6 papers), Biosimilars and Bioanalytical Methods (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Bacteriophages and microbial interactions (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). The work is most often cited by research in Hepatology (599 citations), Virology (78 citations), Immunology (308 citations), Epidemiology (439 citations) and Radiology, Nuclear Medicine and Imaging (264 citations). Martin Lechmann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include T. Jake Liang, Tilman Sauerbruch, Ulrich Spengler, Kazumoto Murata, G. Jung, Rolf Kaiser, Jujin Satoi, Rainer P. Woitas, John Vergalla and Harvey J. Alter. Their work appears in journals such as Hepatology, mAbs, Journal of Hepatology, Human Gene Therapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.